{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:28:50Z","timestamp":1793500130894,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 CA23766"],"award-info":[{"award-number":["P01 CA23766"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jtct.2025.07.006","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T22:39:19Z","timestamp":1752619159000},"page":"938.e1-938.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1929-5705","authenticated-orcid":false,"given":"Stephen","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0312-1205","authenticated-orcid":false,"given":"Grashma","family":"Vadakkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-974X","authenticated-orcid":false,"given":"Samantha","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Murillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5017-1583","authenticated-orcid":false,"given":"Warren","family":"Fingrut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"DeRespiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Monaco-Cermak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-6954","authenticated-orcid":false,"given":"Mary","family":"Nauffal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5910-4571","authenticated-orcid":false,"given":"Miguel-Angel","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7964-3011","authenticated-orcid":false,"given":"Christina","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneeza","family":"Walji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan L.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtct.2025.07.006_bib0001","doi-asserted-by":"crossref","first-page":"128","DOI":"10.6004\/jnccn.2014.0010","article-title":"Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic","volume":"12","author":"Wildes","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.jtct.2025.07.006_bib0002","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bmt.2016.103","article-title":"Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study","volume":"51","author":"Denzen","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2025.07.006_bib0003","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jamaoncol.2021.7987","article-title":"Financial toxicity of cancer treatment","volume":"8","author":"Hussaini","year":"2022","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.006_bib0004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11899-013-0191-0","article-title":"Impact of the affordable care act on stem cell transplantation","volume":"9","author":"Farnia","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"10.1016\/j.jtct.2025.07.006_bib0005","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial burdens of cancer treatment: a systematic review of risk factors and outcomes","volume":"17","author":"Smith","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"10.1016\/j.jtct.2025.07.006_bib0006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1200\/OP.23.00243","article-title":"financial toxicity and quality of life in patients undergoing stem-cell transplant evaluation: a single-center analysis","volume":"20","author":"Hussaini","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"10.1016\/j.jtct.2025.07.006_bib0007","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"377","key":"10.1016\/j.jtct.2025.07.006_bib0008","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"2017","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jtct.2025.07.006_bib0009","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/S2352-3026(23)00344-7","article-title":"Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"11","author":"Russo","year":"2024","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2025.07.006_bib0010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jtct.2024.05.021","article-title":"Impact of primary letermovir prophylaxis versus preemptive antiviral therapy for cytomegalovirus on economic and clinical outcomes after hematopoietic cell transplantation","volume":"30","author":"Tan","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.07.006_bib0011","article-title":"Antifungal therapy in hematopoietic stem cell transplant recipients","volume":"8","author":"Busca","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"12","key":"10.1016\/j.jtct.2025.07.006_bib0012","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.07.006_bib0013","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbmt.2018.09.040","article-title":"Employment, insurance, and financial experiences of patients with chronic graft-versus-host disease in North America","volume":"25","author":"Khera","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.07.006_bib0014","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.bbmt.2017.04.010","article-title":"Challenges around access to and cost of life-saving medications after allogeneic hematopoietic cell transplantation for Medicare patients","volume":"23","author":"Farnia","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1016\/j.jtct.2025.07.006_bib0015","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.2024.17275","article-title":"Strategies to help patients navigate high prescription drug costs","volume":"332","author":"Lalani","year":"2024","journal-title":"JAMA"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725012916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:39Z","timestamp":1793496579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725012916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666636725012916"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.07.006","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}